MT Newswires
UBS Adjusts Price Target on Perspective Therapeutics to $8 From $7, Maintains Buy Rating
๐
AI Sentiment
Highly Positive
8/10
Latest updates and market news for QXO^B
AI Sentiment
Highly Positive
8/10
AI Sentiment
Highly Positive
9/10
AI Sentiment
Highly Positive
9/10
AI Sentiment
Highly Positive
9/10
AI Sentiment
Negative
2/10
AI Sentiment
Positive
7/10
AI Sentiment
Neutral
4/10
AI Sentiment
Positive
6/10
AI Sentiment
Highly Positive
8/10
Share this news page